Syed Mudassir Jeelani

Dr. Syed Mudassir Jeelani


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Journal of Applied Research on Medicinal and Aromatic Plants
Verified
Journal Article
Closed access
SJSyed Mudassir Jeelani
Syed Mudassir Jeelani
GRGulzar A. Rather
Gulzar A. Rather
ASArti Sharma
Arti Sharma
SLSurrinder K. Lattoo
Surrinder K. Lattoo

30 May 2012 in Protoplasma
Verified
Journal Article
Closed access
PDF file
SKSanjeev Kumar
Sanjeev Kumar
SJSyed Mudassir Jeelani
Syed Mudassir Jeelani
SRSavita Rani
Savita Rani
RGRaghbir Chand Gupta
Raghbir Chand Gupta
SKSantosh Kumari
Santosh Kumari

1 December 2017 in Industrial Crops and Products
Verified
Journal Article
Closed access
SJSyed Mudassir Jeelani
Syed Mudassir Jeelani
UFUmer Farooq
Umer Farooq
AGAjai Prakash Gupta
Ajai Prakash Gupta
SLSurrinder K. Lattoo
Surrinder K. Lattoo

10 July 2019 in BMC Plant Biology
Verified
Journal Article
Open access
PDF file
GRGulzar Ahmad Rather
Gulzar Ahmad Rather
ASArti Sharma
Arti Sharma
SJSyed Mudassir Jeelani
Syed Mudassir Jeelani
PMPrashant Misra
Prashant Misra
VKVeenu Kaul
Veenu Kaul
SLSurrinder K. Lattoo
Surrinder K. Lattoo
Nothapodytes nimmoniana, a plant of pivotal medicinal significance is a source of potent anticancer monoterpene indole alkaloid (MIA) camptothecin (CPT). This compound owes its potency due to topoisomerase-I inhibitory activity. However, biosynthetic and regulatory aspects of CPT biosynthesis so far remain elusive. Production of CPT is also constrained due to unavailability of suitable in vitro experimental system. Contextually, there are two routes for the biosynthesis of MIAs: the mevalonate (MVA) pathway operating in cytosol and the methylerythritol phosphate (MEP) pathway in the plastids. Determination of relative precursor flux through either of these pathways may provide a new vista for manipulating the enhanced CPT production. In present study, specific enzyme inhibitors of MVA (lovastatin) and MEP pathways (fosmidomycin) were used to perturb the metabolic flux in N. nimmoniana. Interaction of both these pathways was investigated at transcriptional level by using qRT-PCR and at metabolite level by evaluating secologanin, tryptamine and CPT contents. In fosmidomycin treated plants, highly significant reduction was observed in both secologanin and CPT accumulation in the range 40–57% and 64–71.5% respectively, while 4.61–7.69% increase was observed in tryptamine content as compared to control. Lovastatin treatment showed reduction in CPT (7–11%) and secologanin (7.5%) accumulation while tryptamine registered slight increase (3.84%) in comparison to control. These inhibitor mediated changes were reflected at transcriptional level via altering expression levels of deoxy-xylulose-5-phosphate reductoisomerase (DXR) and hydroxymethylglutaryl-CoA reductase (HMG). Further, mRNA expression of four more genes downstream to DXR and HMG of MEP and MVA pathways respectively were also investigated. Expression analysis also included secologanin synthase (SLS) and strictosidine synthase (STR) of seco-iridoid pathway. Present investigation also entailed development of an efficient in vitro multiplication system as a precursor to pathway flux studies. Further, a robust Agrobacterium-mediated transformed hairy root protocol was also developed for its amenability for up-scaling as a future prospect. Metabolic and transcriptional changes reveal differential efficacy of cytosolic and plastidial inhibitors in context to pathway flux perturbations on seco-iridoid end-product camptothecin. MEP pathway plausibly is the major precursor contributor towards CPT production. These empirical findings allude towards developing suitable biotechnological interventions for enhanced CPT production.

11 April 2012 in Journal of Systematics and Evolution
Verified
Journal Article
Closed access
PDF file
SJSyed Mudassir Jeelani
Syed Mudassir Jeelani
SKSantosh Kumari
Santosh Kumari
RGRaghbir Chand Gupta
Raghbir Chand Gupta

1 January 2010 in CYTOLOGIA
Verified
Journal Article
Closed access
SJSyed Mudassir Jeelani
Syed Mudassir Jeelani
SRSavita Rani
Savita Rani
SKSanjeev Kumar
Sanjeev Kumar
RGRaghbir Chand Gupta
Raghbir Chand Gupta
SKSantosh Kumari
Santosh Kumari